Yoshiya Kawaguchi

Yoshiya Kawaguchi

Auto-generated profile, based on publicly available information

Yoshiya Kawaguchi

Department of Surgery, Graduate School of Medicine Kyoto University, 54 Shogoin Kawara-cho, Sakyo-ku, Kyoto 606, Japan

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2006 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
AFAkihisa Fukuda
Akihisa Fukuda
YKYoshiya Kawaguchi
Yoshiya Kawaguchi
KFKenichiro FURUYAMA
Kenichiro FURUYAMA
SKSota Kodama
Sota Kodama
MHMasashi Horiguchi
Masashi Horiguchi
TCTsutomu Chiba
Tsutomu Chiba
Ectopic pancreas is a developmental anomaly occasionally found in humans. Hes1, a main effector of Notch signaling, regulates the fate and differentiation of many cell types during development. To gain insights into the role of the Notch pathway in pancreatic fate determination, we combined the use of Hes1-knockout mice and lineage tracing employing the Cre/loxP system to specifically mark pancreatic precursor cells and their progeny in Ptf1a-cre and Rosa26 reporter mice. We show that inactivation of Hes1 induces misexpression of Ptf1a in discrete regions of the primitive stomach and duodenum and throughout the common bile duct. All ectopic Ptf1a-expressing cells were reprogrammed, or transcommitted, to multipotent pancreatic progenitor status and subsequently differentiated into mature pancreatic exocrine, endocrine, and duct cells. This process recapitulated normal pancreatogenesis in terms of morphological and genetic features. Furthermore, analysis of Hes1/Ptf1a double mutants revealed that ectopic Ptf1a-cre lineage–labeled cells adopted the fate of region-appropriate gut epithelium or endocrine cells similarly to Ptf1a-inactivated cells in the native pancreatic buds. Our data demonstrate that the Hes1-mediated Notch pathway is required for region-appropriate specification of pancreas in the developing foregut endoderm through regulation of Ptf1a expression, providing novel insight into the pathogenesis of ectopic pancreas development in a mouse model.

1 September 2008 in Diabetes
Verified
Journal Article
Open access
PDF file
AFAkihisa Fukuda
Akihisa Fukuda
YKYoshiya Kawaguchi
Yoshiya Kawaguchi
KFKenichiro FURUYAMA
Kenichiro FURUYAMA
SKSota Kodama
Sota Kodama
MHMasashi Horiguchi
Masashi Horiguchi
SUShinji Uemoto
Shinji Uemoto
OBJECTIVE—Most pancreatic endocrine cells derive from Ptf1a-expressing progenitor cells. In humans, nonsense mutations in Ptf1a have recently been identified as a cause of permanent neonatal diabetes associated with pancreatic agenesis. The death of Ptf1a-null mice soon after birth has not allowed further insight into the pathogenesis of the disease; it is therefore unclear how much pancreatic endocrine function is dependent on Ptf1a in mammals. This study aims to investigate gene-dosage effects of Ptf1a on pancreas development and function in mice. RESEARCH DESIGN AND METHODS—Combining hypomorphic and null alleles of Ptf1a and Cre-mediated lineage tracing, we followed the cell fate of reduced Ptf1a-expressing progenitors and analyzed pancreas development and function in mice. RESULTS—Reduced Ptf1a dosage resulted in pancreatic hypoplasia and glucose intolerance with insufficient insulin secretion in a dosage-dependent manner. In hypomorphic mutant mice, pancreatic bud size was small and substantial proportions of pancreatic progenitors were misspecified to the common bile duct and duodenal cells. Growth with branching morphogenesis and subsequent exocrine cytodifferentiation was reduced and delayed. Total β-cell number was decreased, proportion of non-β islet cells was increased, and α-cells were abnormally intermingled with β-cells. Interestingly, Pdx1 expression was decreased in early pancreatic progenitors but elevated to normal level at the mid-to-late stages of pancreatogenesis. CONCLUSIONS—The dosage of Ptf1a is crucial for pancreas specification, growth, total β-cell number, islet morphogenesis, and endocrine function. Some neonatal diabetes may be caused by mutation or single nucleotide polymorphisms in the Ptf1a gene that reduce gene expression levels.

21 January 2009 in Journal of Experimental & Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
KNKazuyuki Nagai
Kazuyuki Nagai
RDRyuichiro Doi
Ryuichiro Doi
FKFumihiko Katagiri
Fumihiko Katagiri
TITatsuo Ito
Tatsuo Ito
AKAtsushi Kida
Atsushi Kida
SUShinji Uemoto
Shinji Uemoto
Background: KiSS-1 was identified as a metastasis-suppressing gene in melanoma cells. The KiSS-1 gene product (metastin) was isolated from human placenta as the ligand of GPR54, a G-protein-coupled receptor. The role of metastin and GPR54 in tumor progression is not fully understood. Methods: We investigated the clinical significance of metastin and GPR54 expression in pancreatic cancer. We evaluated immunohistochemical expression of metastin and GPR54 in pancreatic ductal adenocarcinoma tissues obtained from 53 consecutive patients who underwent resection between July 2003 and May 2007 at Kyoto University Hospital. In 23 consecutive patients, the plasma metastin level was measured before surgery by enzyme immunoassay. Results: Strong immunohistochemical expression of metastin was detected in 13 tumors (24.5%), while strong expression of GPR54 was detected in 30 tumors (56.6%). Tumors that were negative for both metastin and GPR54 expression were significantly larger than tumors that were positive for either metastin or GPR54 (p = 0.047). Recurrence was less frequent in patients who had metastin-positive tumors compared with those who had metastin-negative tumors (38.5% versus 70.0%, p = 0.04). Strong expression of metastin and GPR54 was significantly correlated with longer survival (p = 0.02). Metastin expression by pancreatic cancer was an independent prognostic factor for longer survival (hazard ratio, 2.1; 95% confidence interval, 1.1–4.7; p = 0.03), and the patients with a high plasma metastin level (n = 6) did not die after surgical resection. Conclusion: Strong expression of metastin and GPR54 by pancreatic cancer is associated with longer survival. Metastin expression is an independent prognostic factor for the survival of pancreatic cancer patients. The plasma metastin level could become a noninvasive prognostic factor for the assessment of pancreatic cancer.

1 March 2006 in Gastroenterology
Verified
Journal Article
Closed access
PDF file
AFAkihisa Fukuda
Akihisa Fukuda
YKYoshiya Kawaguchi
Yoshiya Kawaguchi
KFKenichiro FURUYAMA
Kenichiro FURUYAMA
SKSota Kodama
Sota Kodama
TKTakeshi Kuhara
Takeshi Kuhara
TCTsutomu Chiba
Tsutomu Chiba

29 July 2010 in Journal of Hepato-Biliary-Pancreatic Sciences
Verified
Journal Article
Closed access
YKYoshiya Kawaguchi
Yoshiya Kawaguchi
KTKyoichi Takaori
Kyoichi Takaori
SUShinji Uemoto
Shinji Uemoto